1-20 of 23
Mark C. Willingham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B37: PSCA haploinsufficiency enhances prostate tumor growth in prostate-specific Pten knockout mice

Free
Miranda L. Moore, Shuai Tang, Mark C. Willingham, Purnima Dubey
Journal: Cancer Research
Cancer Res (2009) 69 (23_Supplement): B37.
https://doi.org/10.1158/0008-5472.FBCR09-B37
Published: 28 October 2014
View articletitled, Abstract B37: PSCA haploinsufficiency enhances prostate tumor growth in prostate-specific Pten knockout mice
Journal Articles

Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development

Available to Purchase
Pankaj Taneja, Dejan Maglic, Fumitake Kai, Takayuki Sugiyama, Robert D. Kendig, Donna P. Frazier, Mark C. Willingham, Kazushi Inoue
Journal: Cancer Research
Cancer Res (2010) 70 (22): 9084–9094.
https://doi.org/10.1158/0008-5472.CAN-10-0159
Published: 14 November 2010
View articletitled, Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development
Open the PDF for Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development in another window
Includes: Supplementary data
Journal Articles

In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice

Available to Purchase
Elizabeth J. Akins, Miranda L. Moore, Shuai Tang, Mark C. Willingham, Janet A. Tooze, Purnima Dubey
Journal: Cancer Research
Cancer Res (2010) 70 (9): 3473–3482.
https://doi.org/10.1158/0008-5472.CAN-09-2490
Published: 28 April 2010
View articletitled, In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice
Open the PDF for In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice in another window
Includes: Supplementary data
Journal Articles

Abstract 1096: Arf-independent activation of p53 by the Dmp1 tumor suppressor

Free
Fumitake Kai, Robert D. Kendig, Donna P. Frazier, Pankaj Taneja, Dejan Maglic, Takayuki Sugiyama, Elizabeth A. Fry, Mark C. Willingham, Kazushi Inoue
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1096.
https://doi.org/10.1158/1538-7445.AM10-1096
Published: 15 April 2010
View articletitled, Abstract 1096: Arf-independent activation of p53 by the Dmp1 tumor suppressor
Journal Articles

Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level

Available to Purchase
Sudipto Das, Yoonsoo Hahn, Dawn A. Walker, Satoshi Nagata, Mark C. Willingham, Donna M. Peehl, Tapan K. Bera, Byungkook Lee, Ira Pastan
Journal: Cancer Research
Cancer Res (2008) 68 (15): 6306–6312.
https://doi.org/10.1158/0008-5472.CAN-08-0870
Published: 01 August 2008
View articletitled, Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level
Open the PDF for Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level in another window
Includes: Supplementary data
Journal Articles

NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells

Available to Purchase
Sudipto Das, Yoonsoo Hahn, Satoshi Nagata, Mark C. Willingham, Tapan K. Bera, Byungkook Lee, Ira Pastan
Journal: Cancer Research
Cancer Res (2007) 67 (4): 1594–1601.
https://doi.org/10.1158/0008-5472.CAN-06-2673
Published: 16 February 2007
View articletitled, NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells
Open the PDF for NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells in another window
Journal Articles

Phase I and phase II enzyme polymorphisms and p53 mutations in breast cancer.

Free
Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, Douglass L. Case, Sommer N. Knight, Nancy D. Perrier, Peter Rubin, Gary B. Sherrill, Cindy S. Shaw, Lisa A. Carey, Lynda R. Sawyer, Mark C. Willingham, Mark S. Miller
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1267.
Published: 15 April 2006
View articletitled, Phase I and phase II enzyme polymorphisms and p53 mutations in breast cancer.
Journal Articles

Polymorphisms in Phase I and Phase II enzymes and mutations in p53

Free
Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, Sommer N. Knight, Nancy D. Perrier, Jessica Watkins, Elisabeth Curtis, Peter Rubin, Gary B. Sherrill, Cindy S. Shaw, Mark C. Willingham, Edward S. Peters, Mark S. Miller
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1162–1163.
Published: 01 May 2005
View articletitled, Polymorphisms in Phase I and Phase II enzymes and mutations in p53
Journal Articles

Synergistic cytotoxicity of combinations of DAB389EGF and IL13PE38QQR fusion proteins on human glioma cell lines.

Free
Tie F. Liu, Mark C. Willingham, Stephen B. Tatter, Kimberley A. Cohen, Corinne A. Lowe, Andrew Thorburn, Arthur E. Frankel
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 507–508.
Published: 01 April 2004
View articletitled, Synergistic cytotoxicity of combinations of DAB389EGF and IL13PE38QQR fusion proteins on human glioma cell lines.
Journal Articles

Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis

Available to Purchase
Hao Ying, Hideyo Suzuki, Li Zhao, Mark C. Willingham, Paul Meltzer, Sheue-Yann Cheng
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5274–5280.
Published: 18 September 2003
View articletitled, Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis
Open the PDF for Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis in another window
Journal Articles

A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells

Available to Purchase
Tie Fu Liu, Kimberley A. Cohen, Jason G. Ramage, Mark C. Willingham, Andrew M. Thorburn, Arthur E. Frankel
Journal: Cancer Research
Cancer Res (2003) 63 (8): 1834–1837.
Published: 15 April 2003
View articletitled, A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells
Open the PDF for A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells in another window
Journal Articles

Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells

Available to Purchase
Anthony J. Trimboli, B. Moseley Waite, Gen-ichi Atsumi, Alfred N. Fonteh, Andrew M. Namen, Carl E. Clay, Tim E. Kute, Kevin P. High, Mark C. Willingham, Floyd H. Chilton
Journal: Cancer Research
Cancer Res (1999) 59 (24): 6171–6177.
Published: 15 December 1999
View articletitled, Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells
Open the PDF for Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells in another window
Journal Articles

Interleukin 2 (IL-2) Receptor Expression and Sensitivity to Diphtheria Fusion Toxin DAB389IL-2 in Cultured Hematopoietic Cells

Available to Purchase
Gian G. Re, Cory Waters, Louis Poisson, Mark C. Willingham, Kazuo Sugamura, Arthur E. Frankel
Journal: Cancer Research
Cancer Res (1996) 56 (11): 2590–2595.
Published: 01 June 1996
View articletitled, Interleukin 2 (IL-2) Receptor Expression and Sensitivity to Diphtheria Fusion Toxin DAB389IL-2 in Cultured Hematopoietic Cells
Open the PDF for Interleukin 2 (IL-2) Receptor Expression and Sensitivity to Diphtheria Fusion Toxin DAB389IL-2 in Cultured Hematopoietic Cells in another window
Journal Articles

Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

Available to Purchase
Craig J. Reist, Gary E. Archer, Shekar N. Kurpad, Carol J. Wikstrand, Ganesan Vaidyanathan, Mark C. Willingham, David K. Moscatello, Albert J. Wong, Darell D. Bigner, Michael R. Zalutsky
Journal: Cancer Research
Cancer Res (1995) 55 (19): 4375–4382.
Published: 01 October 1995
View articletitled, Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts
Open the PDF for Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts in another window
Journal Articles

Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys

Available to Purchase
Lee H. Pai, Janendra K. Batra, David J. FitzGerald, Mark C. Willingham, Ira Pastan
Journal: Cancer Research
Cancer Res (1992) 52 (11): 3189–3193.
Published: 01 June 1992
View articletitled, Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys
Open the PDF for Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys in another window
Journal Articles

Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium

Available to Purchase
Kai Chang, Lee H. Pai, Janendra K. Batra, Ira Pastan, Mark C. Willingham
Journal: Cancer Research
Cancer Res (1992) 52 (1): 181–186.
Published: 01 January 1992
View articletitled, Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium
Open the PDF for Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium in another window
Journal Articles

Characterization of Monoclonal Antibodies B1 and B3 That React with Mucinous Adenocarcinomas

Available to Purchase
Ira Pastan, Elizabeth T. Lovelace, Maria G. Gallo, Angelina V. Rutherford, John L. Magnani, Mark C. Willingham
Journal: Cancer Research
Cancer Res (1991) 51 (14): 3781–3787.
Published: 01 July 1991
View articletitled, Characterization of Monoclonal Antibodies B1 and B3 That React with Mucinous Adenocarcinomas
Open the PDF for Characterization of Monoclonal Antibodies B1 and B3 That React with Mucinous Adenocarcinomas in another window
Journal Articles

Enhancement of the Activity of Immunotoxins by Analogues of Verapamil

Available to Purchase
Robert Pirker, David J. P. FitzGerald, Manfred Raschack, Zimmermann Frank, Mark C. Willingham, Ira Pastan
Journal: Cancer Research
Cancer Res (1989) 49 (17): 4791–4795.
Published: 01 September 1989
View articletitled, Enhancement of the Activity of Immunotoxins by Analogues of Verapamil
Open the PDF for Enhancement of the Activity of Immunotoxins by Analogues of Verapamil in another window
Journal Articles

Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice

Available to Purchase
John W. Pearson, David J. P. FitzGerald, Mark C. Willingham, Robert H. Wiltrout, Ira Pastan, Dan L. Longo
Journal: Cancer Research
Cancer Res (1989) 49 (13): 3562–3567.
Published: 01 July 1989
View articletitled, Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice
Open the PDF for Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice in another window
Journal Articles

Enhancement of the Activity of Immunotoxins Made with Either Ricin A Chain or Pseudomonas Exotoxin in Human Ovarian and Epidermoid Carcinoma Cell Lines

Available to Purchase
Robert Pirker, David J. P. FitzGerald, Mark C. Willingham, Ira Pastan
Journal: Cancer Research
Cancer Res (1988) 48 (14): 3919–3923.
Published: 01 July 1988
View articletitled, Enhancement of the Activity of Immunotoxins Made with Either Ricin A Chain or Pseudomonas Exotoxin in Human Ovarian and Epidermoid Carcinoma Cell Lines
Open the PDF for Enhancement of the Activity of Immunotoxins Made with Either Ricin A Chain or Pseudomonas Exotoxin in Human Ovarian and Epidermoid Carcinoma Cell Lines in another window